2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY

The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein.

Saved in:
Bibliographic Details
Main Authors LINDEN, JOEL M, FIGLER, ROBERT ALAN, MURPHREE, LAUREN J, MACDONALD, TIMOTHY L, RIEGER, JAYSON M, SULLIVAN, GAIL W
Format Patent
LanguageEnglish
French
Published 30.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein.
AbstractList The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein.
Author MURPHREE, LAUREN J
FIGLER, ROBERT ALAN
MACDONALD, TIMOTHY L
LINDEN, JOEL M
SULLIVAN, GAIL W
RIEGER, JAYSON M
Author_xml – fullname: LINDEN, JOEL M
– fullname: FIGLER, ROBERT ALAN
– fullname: MURPHREE, LAUREN J
– fullname: MACDONALD, TIMOTHY L
– fullname: RIEGER, JAYSON M
– fullname: SULLIVAN, GAIL W
BookMark eNqFyr0OgjAQAOAOOvj3DN7mxFIDup6llEuw19AKYSLE1MkACb5_XNydvuXbitU4jXEjWpm4ml1nuwow15Y9WQ1osWLjoaVQwp1zKkjnkJ6Smm7sNZiaH85DiQ1ZAygR0LAlHwBVoIZCtxfr1_Be4uHnThwLHVSZxHnq4zIPzzjGT69QppfsKjN1_j--DdAxjg
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ANALOGUES DE 2-PROPYNYLE ADENOSINE COMPRENANT DES GROUPES 5'-RIBOSE MODIFIES PRESENTANT UNE ACTIVITE AGONISTE A2A
ExternalDocumentID CA2576826C
GroupedDBID EVB
ID FETCH-epo_espacenet_CA2576826C3
IEDL.DBID EVB
IngestDate Fri Jul 19 15:57:05 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CA2576826C3
Notes Application Number: CA20052576826
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140930&DB=EPODOC&CC=CA&NR=2576826C
ParticipantIDs epo_espacenet_CA2576826C
PublicationCentury 2000
PublicationDate 20140930
PublicationDateYYYYMMDD 2014-09-30
PublicationDate_xml – month: 09
  year: 2014
  text: 20140930
  day: 30
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies ADENOSINE THERAPEUTICS LLC
UNIVERSITY OF VIRGINIA PATENT FOUNDATION
RelatedCompanies_xml – name: ADENOSINE THERAPEUTICS LLC
– name: UNIVERSITY OF VIRGINIA PATENT FOUNDATION
Score 2.9498332
Snippet The invention provides compounds having the following general formula (I): wherein X, R1, R2, R7 and Z are as described herein.
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SUGARS
Title 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20140930&DB=EPODOC&locale=&CC=CA&NR=2576826C
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3fT8IwEL4gGvVNUYO_-2Dm0yKOMeBhMaXbWA2sC5sgT2RsEH0ZRGb8971WUF94a9rk0l7y9e7a7-4A7ow52qQ2Ii3LWhigJAgp9JvrupkapjR45qMqX9wPLP_FfH5tvJbgbZMLo-qEfqniiIioFPFeqPt6-feI5Shu5eph-o5Tiycvth1tHR3L6k31muZ0bDcUjmAaYzajWjCwlV9tWGwHdtGJbkrylzvsyJyU5X-D4h3BXoiy8uIYSrO8Agds03etAvv99Xc3DtfIW53AyNDDgQjHwbhHUHmBkO0yCA1oT3QjMuKxT_rC4R53HdK41we8IyKXKFJ9RHw65EGXUIMS2hUBj2IiySNDHo9P4dZzY-bruMPJrzImjG6OUj-Dcr7IZ1UgVpZmViubN2tZKnkuidlMjEaSmu1aij5O-xyq26RcbF-6hEOp0h92xBWUi4_P2TWa4GJ6o7T3DepQgms
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOJNUYM_6cHM0yKOMeCwmNFtrLq1C5v8OJGxQfQyiMz479tWUC_cmjZp2pd8fe-1X78HcKctuE_qcqRlWYcnKAmHFI-bm6qearpwePqjlC8OqOG96s_j1rgEb9u_MFIn9EuKI3JEpRzvhTyvV3-XWLbkVq4fZu-8a_nkxqatbLJjod7UbCh2z3RCZjOsYGxiS6EDU8bVmoH3YJ83OkJl3xn2xJ-U1X-H4h7DQcjnyosTKM3zKlTwtu5aFQ6DzXM3b26Qtz6FkaaGAxZO6MRH3HiUiXIZyKKWz_oRGpHYQwGziUscG7Xu1QHpschBklQfIc8aEtpHlmYhq88oiWIkyCNDEk_OoO46MfZUvsLprzGm2NpupXkO5XyZz2uAjCzNjE62aDeyVPBcEr2daK0k1buNlMc43Quo7ZrlcvdQHSpeHPhTn9CXKzgS5v1hSlxDufj4nN9wd1zMbqUlvwEwY4Vb
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=2-PROPYNYL+ADENOSINE+ANALOGS+WITH+MODIFIED+5%27-RIBOSE+GROUPS+HAVING+A2A+AGONIST+ACTIVITY&rft.inventor=LINDEN%2C+JOEL+M&rft.inventor=FIGLER%2C+ROBERT+ALAN&rft.inventor=MURPHREE%2C+LAUREN+J&rft.inventor=MACDONALD%2C+TIMOTHY+L&rft.inventor=RIEGER%2C+JAYSON+M&rft.inventor=SULLIVAN%2C+GAIL+W&rft.date=2014-09-30&rft.externalDBID=C&rft.externalDocID=CA2576826C